Accelerating Drug Discovery: Life Science and IT Leaders Explore the Power of Artificial Intelligence April 15-17 in Boston

AI to Take Center Stage at Bio-IT World Conference & Expo, the Hub for Pharmaceutical, Biotech and IT Collaboration

Recognizing the critical role of artificial intelligence (AI) in accelerating drug discovery, Bio-IT World Conference & Expo is offering expanded content on this pivotal technology at its 23rd annual event. Convening April 15-17, 2024 in Boston, Bio-IT World will bring together more than 3,000 attendees seeking to collaborate with other top pharmaceutical, biotech, and technology leaders. Three of the ten technology conference tracks, comprising dozens of sessions, will be AI-focused—covering Generative AI, AI for Drug Discovery and Development, and AI for Oncology, Precision Medicine, and Health. “The integration of AI and machine learning (ML) in life sciences offers unparalleled advantages—speeding the identification of drug candidates, improving precision in treatment approaches, and optimizing experimental processes. These technologies promise more rapid therapeutic advances,” said Cindy Crowninshield, RDN, LDN, Executive Event Director.

Login Or Register To Read Full Story